Search - tctmd.com

Displaying 341 - 360 of 472

Sort: Relevancy | Date

Presentation TVT 2023

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

Presenter: Rahul Sharma

June 08, 2023

Presentation TVT 2023

Pressure Gradients and Mortality Following Transcatheter Mitral Valve in Valve and Valve in Ring

Presenter: Amr Abbas

June 08, 2023

Presentation TVT 2023

Mitral Valve Repair versus Replacement after Transcatheter Edge-to-Edge Mitral Repair: Results from The CUTTING-EDGE Registry

Presenter: Syed Zaid

June 08, 2023

Presentation TVT 2023

M-TEER in Secondary MR: Time to Re-Evaluate Timing and Patient Selection?

Presenter: Niklas Schofer

June 08, 2023

Presentation TVT 2023

M-TEER in Atrial Functional MR in HFpEF Patients

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

M-TEER in Severe LV Dysfunction as a Bridge to Advanced HF Therapies

Presenter: Mark Reisman

June 08, 2023

Presentation TVT 2023

Contemporary Outcomes of Transcatheter Transeptal Mitral Valve in Valve in the United States

Presenter: Kashish Goel

June 08, 2023

Presentation TVT 2023

Longer-Term Clinical and Echocardiography Follow-up of Transcatheter Mitral Valve Replacement with the Trans-apical Intrepid System

Presenter: Martin Leon

June 08, 2023

Presentation TVT 2023

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

Presenter: Colin Barker

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

Presenter: Philipp Lurz

June 08, 2023

Presentation TVT 2023

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

Presenter: Matthew Price

June 08, 2023

Presentation TVT 2023

M-TEER in HF Patients With Secondary MR: A “Foundational” or Bridge Therapy?

Presenter: Paul Grayburn

June 08, 2023

Presentation TVT 2023

M-TEER for Severe MR and Cardiogenic Shock

Presenter: David Rizik

June 08, 2023

Presentation TVT 2023

Case Resolution 3: Recurrent MR After M-TEER

Presenter: Jonathan Schwartz

June 08, 2023

Presentation TVT 2023

Hemi Valve Mitral Butterfly: Technology and Program Update

Presenter: Mathew Williams

June 08, 2023

Presentation TVT 2023

SPOTLIGHT INNOVATION LECTURE: Transcatheter Posterior Leaflet Augmentation: Technology Principles, Anatomical Targets and Challenges

Presenter: Vinayak Bapat

June 08, 2023

Presentation TVT 2023

Life After M-TEER: Recurrent MR After M-TEER - Therapeutic Options

Presenter: Vinayak Bapat

June 08, 2023

Presentation TVT 2023

Case Presentation 3: Recurrent MR After M-TEER

Presenter: Jonathan Schwartz

June 08, 2023

Presentation TVT 2023

Case Resolution 2: Conflicting Hemodynamic Results Post-TEER

Presenter: Isida Byku

June 08, 2023

Advertisement

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

Pressure Gradients and Mortality Following Transcatheter Mitral Valve in Valve and Valve in Ring

Mitral Valve Repair versus Replacement after Transcatheter Edge-to-Edge Mitral Repair: Results from The CUTTING-EDGE Registry

M-TEER in Secondary MR: Time to Re-Evaluate Timing and Patient Selection?

M-TEER in Atrial Functional MR in HFpEF Patients

M-TEER in Severe LV Dysfunction as a Bridge to Advanced HF Therapies

Contemporary Outcomes of Transcatheter Transeptal Mitral Valve in Valve in the United States

Longer-Term Clinical and Echocardiography Follow-up of Transcatheter Mitral Valve Replacement with the Trans-apical Intrepid System

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

SPOTLIGHT LECTURE: TEER in Secondary MR- Clinical Evidence, Patient Selection, and Controversies

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

M-TEER in HF Patients With Secondary MR: A “Foundational” or Bridge Therapy?

M-TEER for Severe MR and Cardiogenic Shock

Case Resolution 3: Recurrent MR After M-TEER

Hemi Valve Mitral Butterfly: Technology and Program Update

SPOTLIGHT INNOVATION LECTURE: Transcatheter Posterior Leaflet Augmentation: Technology Principles, Anatomical Targets and Challenges

Life After M-TEER: Recurrent MR After M-TEER - Therapeutic Options

Case Presentation 3: Recurrent MR After M-TEER

Case Resolution 2: Conflicting Hemodynamic Results Post-TEER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content